Search details
1.
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in MajesTEC-1.
Blood
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38657201
2.
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.
Int J Cancer
; 143(5): 1236-1248, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-29574703
3.
Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
Cancer
; 124(6): 1216-1224, 2018 03 15.
Article
in English
| MEDLINE | ID: mdl-29266182
4.
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice.
J Exp Med
; 218(4)2021 04 05.
Article
in English
| MEDLINE | ID: mdl-33566112
5.
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.
Prostate Cancer Prostatic Dis
; 24(2): 448-456, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33009489
Results
1 -
5
de 5
1
Next >
>>